Randomized Open Label Study Comparing the Metabolic Control of Kidney Transplant Recipients With Type 2 Diabetes Receiving Either Prograf or Neoral as Part of a ATG Induction, Prednisone Free and Monitored MMF Immunosuppressive Regimen
Phase of Trial: Phase IV
Latest Information Update: 06 Dec 2016
At a glance
- Drugs Ciclosporin (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 29 Nov 2016 Status changed from recruiting to completed.
- 02 Dec 2006 New trial record.